Open AccessPharmacological correction of no-reflow phenomenon in myocardial infarction treatment
Author(s) -
T. Yu. Mamonova,
В. А. Марков,
В. В. Удут
Publication year - 2009
Publication title -
bûlletenʹ sibirskoj mediciny
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.135
H-Index - 3
eISSN - 1819-3684
pISSN - 1682-0363
DOI - 10.20538/1682-0363-2009-2-118-122
Subject(s) - carvedilol , myocardial infarction , no reflow phenomenon , medicine , necrosis , cardiology , infarction , heart failure , percutaneous coronary intervention
This article presents the research findings on the impact of carvedilol on the course of the necrosis myocardium focus and malone dialdegid concentration with patients, afflicted with acute myocardial infarction. The study proves that carvedilol slows down the necrosis focus formation and relieves the intensity of the no-reflow phenomenon as well as the oxydative stress, in case it is administered prior to the trombolytic therapy.